US 12144869
Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates
granted A61KA61K31/502A61K47/6803
Quick answer
US patent 12144869 (Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates) held by Sutro Biopharma, Inc. expires Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sutro Biopharma, Inc.
- Grant date
- Tue Nov 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/502, A61K47/6803, A61K47/68037, A61K47/6805